Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome

European Journal of Endocrinology

Volumn 161, Issue 4, 2009, Pages 575-582

  Wehr, E ^a   Pilz, S ^a   Schweighofer, N ^a   Giuliani, A ^a   Kopera, D ^a   Pieber, T R ^a   Obermayer Pietsch, B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; VITAMIN D; 25 HYDROXYERGOCALCIFEROL; HORMONE; LIPID;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SEASONAL VARIATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADOLESCENT; BLOOD; COHORT ANALYSIS; GENETICS; GLUCOSE INTOLERANCE; HEMODYNAMICS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

25-HYDROXYVITAMIN D 2; ADOLESCENT; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HEMODYNAMICS; HORMONES; HUMANS; INSULIN; LIPIDS; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 70349771363     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0432     Document Type: Article

References (40)

1. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438. (Pubitemid 32269197)
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011. (Pubitemid 30644187)
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800. (Pubitemid 28009567)
4. Wehr E, Möller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, Pieber TR & Obermayer-Pietsch B. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wiener Klinische Wochenschrift 2009 121 262-269.
5. Ehrmann DA. Polycystic ovary syndrome. New England Journal of Medicine 2005 352 1223-1236.
6. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K & Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experimental and Clinical Endocrinology and Diabetes 2006 114 577-583. (Pubitemid 46087264)
7. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281.
8. Pittas AG, Lau J, Hu FB & Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 2017-2029. (Pubitemid 46997093)
9. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, Li YC & Rodriguez-Iturbe B. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney International 2008 74 1394-1402.
10. Chiu KC, Chu A, Go VL & Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. American Journal of Clinical Nutrition 2004 79 820-825. (Pubitemid 41103882)
11. Isaia G, Giorgino R & Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001 24 1496.
12. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS & Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertility and Sterility, 2009 In Press DOI: 10.1016/j.fertnstert.2008.11.031.
13. Konradsen S, Ag H, Lindberg F, Hexeberg S & Jorde R. Serum 1,25- dihydroxy vitamin D is inversely associated with body mass index. European Journal of Nutrition 2008 47 87-91.
14. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J & Yanovski JA. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism 2004 89 1196-1199. (Pubitemid 38368412)
15. The Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
16. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002 106 3143-3421.
17. Legro RS, Castracane VD & Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstetrical and Gynecological Survey 2004 59 141-154. (Pubitemid 38140845)
18. Mosekilde L. Vitamin D and the elderly. Clinical Endocrinology 2005 62 265-281.
19. Arunabh S, Pollack S, Yeh J & Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism 2003 88 157-161. (Pubitemid 36115158)
20. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL & Polonsky KS. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1995 96 520-527.
21. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, Mattson LA, Crona N & Lundberg PA. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertility and Sterility 1992 57 505-513.
22. Pilz S, Dobnig H, Winklhofer-Roob B, Riedmüller G, Fischer JE, Seelhorst U, Wellnitz B, Boehm BO & März W. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiology, Biomarkers and Prevention 2008 17 1228-1233.
23. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO & Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. Journal of Clinical Endocrinology and Metabolism 2008 93 3927-3935.
24. Kotsa K, Yavropoulou MP, Anastasiou O & Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertility and Sterility, 2008 In Press DOI: 10.1016/j.fertnstert.2008.07.1757.
25. Scragg R, Sowers M & Bell C, Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 27 2813-2818. (Pubitemid 39565042)
26. Baynes KC, Boucher BJ, Feskens EJ & Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997 40 344-347. (Pubitemid 27096561)
27. Forouhi NG, Luan J, Cooper A, Boucher BJ & Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008 57 2619-2625.
28. Bikle D. Nonclassic actions of vitamin D. Journal of Clinical Endocrinology and Metabolism 2009 94 26-34.
29. Shoelson SE, Herrero L & Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007 132 2169-2180.
30. Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F & Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young middle-eastern population. European Journal of Endocrinology 2009 160 965-971.
31. Diamanti-Kandarakis E, Kandaraki E, Christakou C & Panidis D. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Obesity Reviews 2009 10 431-434.
32. Wortsman J, Matsuoka LY, Chen TC, Lu Z & Holick MF. Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition 2000 72 690-693.
33. Compston JE, Vedi S, Ledger JE,Webb A, Gazet JC & Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. American Journal of Clinical Nutrition 1981 34 2359-2363. (Pubitemid 12176062)
34. Kamycheva E, Joakimsen RM & Jorde R. Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway. Journal of Nutrition 2003 133 102-106. (Pubitemid 36070586)
35. Ortega RM, Aparicio A, Rodríguez-Rodríguez E, Bermejo LM, Perea JM, López-Sobaler AM, Ruiz-Roso B & Andrés P. Preliminary data about the influence of vitamin D status on the loss of body fat in young overweight/obese women following two types of hypocaloric diet. British Journal of Nutrition 2008 100 269-272.
36. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW & Nestler JE. Glucose intolerance in polycystic ovary syndrome - a position statement of the androgen excess society. Journal of Clinical Endocrinology and Metabolism 2007 92 4546-4556.
37. Panidis D, Balaris C, Farmakiotis D, Rousso D, Kourtis A, Balaris V, Katsikis I, Zournatzi V & Diamanti-Kandarakis E. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clinical Chemistry 2005 51 1691-1697. (Pubitemid 41233105)
38. Glintborg D, Andersen M, Hagen C & Hermann AP. Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism. Clinical Endocrinology 2005 62 683-691.
39. Maïmoun L, Simar D, Malatesta D, Caillaud C, Peruchon E, Couret I, Rossi M & Mariano-Goulart D. Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects. British Journal of Sports Medicine 2005 39 497-502. (Pubitemid 41081325)
40. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P & Morales-Torres J, on behalf of the IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International, 2009 In Press DOI: 10.1007/s00198-009-0954-6.